The second phase project of neutral borosilicate pharmaceutical glass, with a total investment of nearly 236 million yuan, which adopts the advanced design concept of one kiln and three lines and uses innovative platinum technology, built a new generation of neutral borosilicate pharmaceutical glass production line with better product quality and performance level than the previous generation. After the project is put into operation, the annual output value is expected to reach 160 million yuan.

 

“The neutral borosilicate 5.0 pharmaceutical glass products produced by Kibing have overcome the technical difficulties, and our products can be widely used for high value-added drugs such as blood products and vaccine, and special drugs with high PH value. We will also continue our efforts to ‘establish a national brand of neutral borosilicate 5.0 pharmaceutical glass’ and guard the national health,” said Cai Canjing, general manager of Hunan Kibing Medical Materials.